After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer (CRC), which could inject some much-needed sales growth into the product. The FDA has given ...

In a judgment of far-reaching significance for India's pharmaceutical and patent jurisprudence, the Delhi High Court has ...

BioNTech with continued late-stage pipeline progress with candidates across immunomodulators, antibody-drug conjugates and mRNA immunotherapiesExpected 2026 oncology ...

Market to reach US$ 158.9 Bn by 2036 at 7.0% CAGR, driven by vehicle electrification and software-defined vehicles.

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

North America held a dominan Market position, capturing more than a 33.6% share, holding USD 1.4 Billion revenue.

PDF and Word files each serve a purpose—one’s made for editing, the other for sharing. Knowing when to switch can help you save time, avoid formatting issues, and keep things moving. Let’s take a ...